Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122940453 | 12294045 | 3 | F | 20160223 | 20160921 | 20160422 | 20160926 | PER | US-ELI_LILLY_AND_COMPANY-US201604000881 | ELI LILLY AND CO | 67.50 | YR | F | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122940453 | 12294045 | 1 | PS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | C455628F | 21318 | 20 | UG | INJECTION | QD | |||||
| 122940453 | 12294045 | 2 | SS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | C471303D | 21318 | 20 | UG | INJECTION | QD | |||||
| 122940453 | 12294045 | 3 | SS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | C471304C | 21318 | 20 | UG | INJECTION | QD | |||||
| 122940453 | 12294045 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 122940453 | 12294045 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | 3000 UNK, UNK | U | 0 | ||||||||||
| 122940453 | 12294045 | 6 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | U | 0 | |||||||||||
| 122940453 | 12294045 | 7 | C | LAMICTAL | LAMOTRIGINE | 1 | U | 0 | |||||||||||
| 122940453 | 12294045 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 122940453 | 12294045 | 9 | C | CALCIUM | CALCIUM | 1 | Unknown | 1200 MG, UNKNOWN | U | 0 | 1200 | MG | |||||||
| 122940453 | 12294045 | 10 | C | GLUCOSAMIN + CHONDROITIN | 2 | U | 0 | ||||||||||||
| 122940453 | 12294045 | 11 | C | ACIDOPHILUS-L | 2 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122940453 | 12294045 | 1 | Osteoporosis |
| 122940453 | 12294045 | 8 | Supplementation therapy |
| 122940453 | 12294045 | 9 | Supplementation therapy |
| 122940453 | 12294045 | 10 | Supplementation therapy |
| 122940453 | 12294045 | 11 | Lactose intolerance |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122940453 | 12294045 | Anxiety | |
| 122940453 | 12294045 | Arthralgia | |
| 122940453 | 12294045 | Blood calcium increased | |
| 122940453 | 12294045 | Dizziness | |
| 122940453 | 12294045 | Eye contusion | |
| 122940453 | 12294045 | Pollakiuria | |
| 122940453 | 12294045 | Ventricular extrasystoles |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122940453 | 12294045 | 1 | 20160223 | 0 | ||
| 122940453 | 12294045 | 9 | 20160616 | 0 |